JP2017528465A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017528465A5 JP2017528465A5 JP2017513409A JP2017513409A JP2017528465A5 JP 2017528465 A5 JP2017528465 A5 JP 2017528465A5 JP 2017513409 A JP2017513409 A JP 2017513409A JP 2017513409 A JP2017513409 A JP 2017513409A JP 2017528465 A5 JP2017528465 A5 JP 2017528465A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- composition
- patient
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021087382A JP7288927B2 (ja) | 2014-09-10 | 2021-05-25 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2023087736A JP7591092B2 (ja) | 2014-09-10 | 2023-05-29 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2024199491A JP2025024104A (ja) | 2014-09-10 | 2024-11-15 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462048512P | 2014-09-10 | 2014-09-10 | |
| US62/048,512 | 2014-09-10 | ||
| PCT/IB2015/056871 WO2016038538A1 (en) | 2014-09-10 | 2015-09-08 | Use of il-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087382A Division JP7288927B2 (ja) | 2014-09-10 | 2021-05-25 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017528465A JP2017528465A (ja) | 2017-09-28 |
| JP2017528465A5 true JP2017528465A5 (enExample) | 2018-10-04 |
Family
ID=54186247
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017513409A Withdrawn JP2017528465A (ja) | 2014-09-10 | 2015-09-08 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ−１７アンタゴニストの使用 |
| JP2021087382A Active JP7288927B2 (ja) | 2014-09-10 | 2021-05-25 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2023087736A Active JP7591092B2 (ja) | 2014-09-10 | 2023-05-29 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2024199491A Pending JP2025024104A (ja) | 2014-09-10 | 2024-11-15 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087382A Active JP7288927B2 (ja) | 2014-09-10 | 2021-05-25 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2023087736A Active JP7591092B2 (ja) | 2014-09-10 | 2023-05-29 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2024199491A Pending JP2025024104A (ja) | 2014-09-10 | 2024-11-15 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US11278618B2 (enExample) |
| EP (2) | EP3191120B1 (enExample) |
| JP (4) | JP2017528465A (enExample) |
| KR (2) | KR20230170796A (enExample) |
| CN (4) | CN115957326A (enExample) |
| AU (2) | AU2015313827C1 (enExample) |
| BR (1) | BR112017003332A2 (enExample) |
| CA (1) | CA2960754A1 (enExample) |
| DK (1) | DK3191120T3 (enExample) |
| ES (1) | ES2981697T3 (enExample) |
| FI (1) | FI3191120T3 (enExample) |
| HR (1) | HRP20240921T1 (enExample) |
| HU (1) | HUE067081T2 (enExample) |
| LT (1) | LT3191120T (enExample) |
| MX (1) | MX2017003216A (enExample) |
| PL (1) | PL3191120T3 (enExample) |
| PT (1) | PT3191120T (enExample) |
| RS (1) | RS65851B1 (enExample) |
| RU (1) | RU2697383C2 (enExample) |
| SI (1) | SI3191120T1 (enExample) |
| SM (1) | SMT202400285T1 (enExample) |
| WO (1) | WO2016038538A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115957326A (zh) | 2014-09-10 | 2023-04-14 | 诺华股份有限公司 | 使用il-17拮抗剂抑制银屑病关节炎患者的结构损伤进展 |
| CN116059350A (zh) | 2015-10-27 | 2023-05-05 | Ucb生物制药有限责任公司 | 使用抗-il-17a/f抗体的治疗方法 |
| TW201842933A (zh) * | 2017-05-05 | 2018-12-16 | 瑞士商諾華公司 | 使用il-17拮抗劑選擇性治療氣喘的方法 |
| CN111032691A (zh) * | 2017-08-23 | 2020-04-17 | 伊莱利利公司 | 生殖器银屑病的治疗 |
| US20210179702A1 (en) * | 2017-11-02 | 2021-06-17 | Novartis Ag | Method of treating tendinopathy using interleukin-17 (il-17) |
| MA56124A (fr) * | 2019-06-04 | 2022-04-13 | Janssen Biotech Inc | Méthode sûre et efficace de traitement de l'arthrite psoriasique au moyen d'un anticorps spécifique anti-il23 |
| KR102576258B1 (ko) | 2019-12-05 | 2023-09-11 | 아주대학교산학협력단 | 펩타이드 또는 이의 혼합물을 유효성분으로 함유하는 조성물 및 이의 의학적 용도 |
| KR102394378B1 (ko) | 2020-10-14 | 2022-05-03 | 한림대학교 산학협력단 | 피부 각질세포에서의 아릴탄화수소 수용체 억제자(AhRR) 과발현 방법 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0417487D0 (en) | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
| GB0425569D0 (en) | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Biological products |
| EP1963368B3 (en) | 2005-12-13 | 2020-06-10 | Eli Lilly And Company | Anti-il-17 antibodies |
| BRPI0706788A2 (pt) | 2006-01-31 | 2011-04-05 | Novartis Ag | anticorpos antagonistas il-17 |
| GB0612928D0 (en) | 2006-06-29 | 2006-08-09 | Ucb Sa | Biological products |
| US7767206B2 (en) | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
| US20100239590A1 (en) | 2007-06-20 | 2010-09-23 | Schering Corporation | Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease |
| US7856118B2 (en) | 2007-07-20 | 2010-12-21 | The Procter & Gamble Company | Methods for recommending a personal care product and tools therefor |
| NZ591484A (en) | 2008-09-29 | 2012-09-28 | Roche Glycart Ag | Antibodies against human il 17 and uses thereof |
| CN103154031A (zh) * | 2010-10-08 | 2013-06-12 | 诺华有限公司 | 利用il-17拮抗剂治疗牛皮癣的方法 |
| BR112013011176A2 (pt) * | 2010-11-05 | 2020-09-01 | Novartis Ag | métodos de tratamento de artrite reumatoide usando antagonistas de il-17 |
| TW201307845A (zh) * | 2010-12-13 | 2013-02-16 | Novartis Ag | 預測方法及利用ｉｌ－１７拮抗劑治療關節炎的方法 |
| EP2783014A1 (en) * | 2011-11-21 | 2014-10-01 | Novartis AG | Methods of treating psoriatic arthritis (psa) using il-17 antagonists and psa response or non- response alleles |
| CN103936854B (zh) * | 2014-04-30 | 2016-08-17 | 北京精益泰翔技术发展有限公司 | 抗il-17a单克隆抗体及其制备与应用 |
| CN115957326A (zh) * | 2014-09-10 | 2023-04-14 | 诺华股份有限公司 | 使用il-17拮抗剂抑制银屑病关节炎患者的结构损伤进展 |
-
2015
- 2015-09-08 CN CN202210788000.7A patent/CN115957326A/zh active Pending
- 2015-09-08 KR KR1020237041277A patent/KR20230170796A/ko not_active Ceased
- 2015-09-08 EP EP15767597.6A patent/EP3191120B1/en active Active
- 2015-09-08 EP EP24169328.2A patent/EP4406969A3/en active Pending
- 2015-09-08 AU AU2015313827A patent/AU2015313827C1/en active Active
- 2015-09-08 RU RU2017107501A patent/RU2697383C2/ru active
- 2015-09-08 ES ES15767597T patent/ES2981697T3/es active Active
- 2015-09-08 PL PL15767597.6T patent/PL3191120T3/pl unknown
- 2015-09-08 DK DK15767597.6T patent/DK3191120T3/da active
- 2015-09-08 FI FIEP15767597.6T patent/FI3191120T3/fi active
- 2015-09-08 MX MX2017003216A patent/MX2017003216A/es unknown
- 2015-09-08 CN CN202210786909.9A patent/CN115944734A/zh active Pending
- 2015-09-08 CN CN202110368292.4A patent/CN113069542A/zh active Pending
- 2015-09-08 HR HRP20240921TT patent/HRP20240921T1/hr unknown
- 2015-09-08 JP JP2017513409A patent/JP2017528465A/ja not_active Withdrawn
- 2015-09-08 HU HUE15767597A patent/HUE067081T2/hu unknown
- 2015-09-08 SI SI201532020T patent/SI3191120T1/sl unknown
- 2015-09-08 KR KR1020177006313A patent/KR20170045240A/ko not_active Ceased
- 2015-09-08 LT LTEPPCT/IB2015/056871T patent/LT3191120T/lt unknown
- 2015-09-08 CN CN201580047920.1A patent/CN107073110A/zh active Pending
- 2015-09-08 SM SM20240285T patent/SMT202400285T1/it unknown
- 2015-09-08 US US15/508,441 patent/US11278618B2/en active Active
- 2015-09-08 WO PCT/IB2015/056871 patent/WO2016038538A1/en not_active Ceased
- 2015-09-08 PT PT157675976T patent/PT3191120T/pt unknown
- 2015-09-08 RS RS20240773A patent/RS65851B1/sr unknown
- 2015-09-08 BR BR112017003332A patent/BR112017003332A2/pt not_active Application Discontinuation
- 2015-09-08 CA CA2960754A patent/CA2960754A1/en active Pending
-
2018
- 2018-02-27 AU AU2018201410A patent/AU2018201410A1/en not_active Abandoned
-
2021
- 2021-05-25 JP JP2021087382A patent/JP7288927B2/ja active Active
-
2022
- 2022-02-15 US US17/672,242 patent/US20220313818A1/en active Pending
-
2023
- 2023-05-29 JP JP2023087736A patent/JP7591092B2/ja active Active
-
2024
- 2024-11-15 JP JP2024199491A patent/JP2025024104A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017528465A5 (enExample) | ||
| US20250066466A1 (en) | Methods of treating non-radiographic axial spondyloarthritis using interleukin-17 (il-17) antagonists | |
| JP6877357B2 (ja) | Ｇｄｆ８阻害剤を用いて、強度及び機能を増加させる方法 | |
| JP2026032035A (ja) | 関節リウマチを治療するための組成物およびこれを使用する方法 | |
| JP7581399B2 (ja) | ブドウ膜炎および黄斑浮腫の処置のためのｉｌ６ｒ抗体を含む組成物およびそれを使用する方法 | |
| JP2017031213A5 (enExample) | ||
| CN108310376A (zh) | 用于治疗类风湿性关节炎的组合物及其使用方法 | |
| RU2013125775A (ru) | Способы лечения ревматоидного артрита с применением антагонистов il-17 | |
| US20220313818A1 (en) | Use of il-17 antagonists to inhibit the progression of structural damage in psoriatic arthritic patients | |
| KR20240164816A (ko) | Il-6r 길항제의 투여에 의한 류마티스성 다발성 근육통을 치료하기 위한 조성물 및 방법 | |
| CN115667301A (zh) | 治疗具有类风湿性关节炎的受试者的疼痛的组合物和方法 | |
| Morel | Infection prevention and vaccination in the rheumatic diseases | |
| EP4688142A1 (en) | Methods for treating eosinophilic gastroenteritis by administering an il-4r antagonist | |
| JP2025530983A (ja) | 二重特異性抗ｐｓｍａ×抗ｃｄ２８抗体を抗ｐｄ－１抗体と組み合わせて、転移性去勢抵抗性前立腺癌を治療する方法 | |
| JP2020517648A5 (enExample) | ||
| HK40110169A (en) | Use of il-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients | |
| NZ761478A (en) | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |